Works matching DE "HORMONE receptor positive breast cancer"

Results: 2397

Sick Time.

Published in:

2021

By:

WAPLES, EMILY

Publication type:

Short Story

Why does hormonal contraception and menopausal hormonal treatment have such a small effect on breast cancer risk?

Published in:

Australian & New Zealand Journal of Obstetrics & Gynaecology, 2024, v. 64, n. 5, p. 427, doi. 10.1111/ajo.13825

By:

Eden, John A.

Publication type:

Article

Initiation of Oral Endocrine Therapy and Survival Benefit Among Women with Early-Stage Breast Cancer.

Published in:

Journal of Women's Health (15409996), 2024, v. 33, n. 11, p. 1509, doi. 10.1089/jwh.2023.0971

By:

Qian, Jingjing;
Truong, Bang

Publication type:

Article

Impact of Alcohol Consumption on Breast Cancer Incidence and Mortality: The Women's Health Study.

Published in:

Journal of Women's Health (15409996), 2024, v. 33, n. 6, p. 705, doi. 10.1089/jwh.2023.1021

By:

Mostofsky, Elizabeth;
Lee, I-Min;
Buring, Julie Elizabeth;
Mukamal, Kenneth Jay

Publication type:

Article

Aspirin and Risk of Specific Breast Cancer Subtype in Women with Diabetes.

Published in:

Journal of Women's Health (15409996), 2023, v. 32, n. 3, p. 341, doi. 10.1089/jwh.2022.0055

By:

Yang, Yi-Sun;
Kornelius, Edy;
Lo, Shih-Chan;
Wang, Yu-Hsun;
Huang, Chien-Ning

Publication type:

Article

Opportunities to Improve Women's Health: Engaging Racial/Ethnic Diverse Women to Provide Biospecimens for Research.

Published in:

Journal of Women's Health (15409996), 2021, v. 30, n. 9, p. 1321, doi. 10.1089/jwh.2020.8502

By:

Edmonds, Megan C.;
Sutton, Arnethea L.;
Cummings, Yvonne;
Sheppard, Vanessa B.

Publication type:

Article

The Use and Concurrent Use of Side Effect Controlling Medications Among Women on Aromatase Inhibitors.

Published in:

Journal of Women's Health (15409996), 2021, v. 30, n. 1, p. 131, doi. 10.1089/jwh.2020.8493

By:

Farkas, Amy H.;
Winn, Aaron;
Pezzin, Liliana E.;
Fergestrom, Nicole;
Laud, Prakash;
Neuner, Joan M.

Publication type:

Article

The race to develop oral SERDs and other novel estrogen receptor inhibitors: recent clinical trial results and impact on treatment options.

Published in:

Cancer & Metastasis Reviews, 2022, v. 41, n. 4, p. 975, doi. 10.1007/s10555-022-10066-y

By:

Wang, Yating;
Tang, Shou-Ching

Publication type:

Article

Obesity and cancer.

Published in:

Cancer & Metastasis Reviews, 2022, v. 41, n. 3, p. 463, doi. 10.1007/s10555-022-10049-z

By:

Gallagher, Emily J.;
LeRoith, Derek

Publication type:

Article

Quantitative evaluation of the efficacy and safety profiles of two types of targeted inhibitors combined with endocrine therapy in ER+/HER2− metastatic breast cancer.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1387, doi. 10.1007/s00228-024-03715-4

By:

Pan, Meiyu;
Lin, Yan;
Liu, Yinhui;
Xu, Ruijuan;
Yang, Jin

Publication type:

Article

An evidence-based review of the outcome of fulvestrant plus a targeted agent versus fulvestrant alone in treating hormone receptor-positive endocrine therapy-resistant metastatic breast cancer.

Published in:

2019

By:

Hua, Yu-Ming

Publication type:

journal article

Therapy of isolated locoregional recurrent carcinoma of the breast.

Published in:

2019

By:

Gabriel, Lena;
Schmidt, Marina;
Juhasz-Böss, Stephanie;
Melchior, Patrick;
von Heesen, Anika;
Schmidt, Gilda;
Kranzhöfer, Nicole;
Solomayer, Erich-Franz;
Juhasz-Böss, Ingolf;
Breitbach, Georg-Peter

Publication type:

journal article

Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer.

Published in:

2019

By:

Stueber, Tanja Nadine;
Weiss, Claire Rachel;
Woeckel, Achim;
Haeusler, Sebastian

Publication type:

journal article

Assessment of ovarian function after chemotherapy in women with early and locally advanced breast cancer from Serbia.

Published in:

2018

By:

Malisic, Emina;
Susnjar, Snezana;
Milovanovic, Jelena;
Todorovic-Rakovic, Natasa;
Kesic, Vesna

Publication type:

journal article

Breast cancer presentation and therapy in migrant versus native German patients: contrasting and convergent data of a retrospective monocentric study.

Published in:

2016

By:

von Au, Alexandra;
Weiler, Ulrike;
Stefanovic, Stefan;
Wallwiener, Markus;
Heil, Joerg;
Golatta, Michael;
Rom, Joachim;
Sohn, Christof;
Schneeweiss, Andreas;
Schuetz, Florian;
Domschke, Christoph

Publication type:

journal article

The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase.

Published in:

Nature, 2015, v. 522, n. 7554, p. 106, doi. 10.1038/nature14492

By:

Cox, Thomas R.;
Rumney, Robin M. H.;
Schoof, Erwin M.;
Perryman, Lara;
Høye, Anette M.;
Agrawal, Ankita;
Bird, Demelza;
Latif, Norain Ab;
Forrest, Hamish;
Evans, Holly R.;
Huggins, Iain D.;
Lang, Georgina;
Linding, Rune;
Gartland, Alison;
Erler, Janine T.

Publication type:

Article

Diabetic Ketoacidosis With the Use of Alpelisib in a Patient With Metastatic Breast Cancer Without Diabetes.

Published in:

JCEM Case Reports, 2024, v. 2, n. 4, p. 1, doi. 10.1210/jcemcr/luae023

By:

Polisetty, Lakshmi;
Selvin, Sneha Teresa;
Tan, Jia Wei

Publication type:

Article

Foreword.

Published in:

touchREVIEWS in Oncology & Haematology, 2024, v. 20, n. 1, p. 1

By:

Merseburger, Axel

Publication type:

Article

Epidemiological Study of Breast Cancer in Erbil, Kurdistan Region.

Published in:

UKH Journal of Science & Engineering, 2023, v. 7, n. 1, p. 11, doi. 10.25079/ukhjse.v7n1y2023.pp11-16

By:

Khoshnaw, Sarkawt M.;
Ganjo, Aryan R.;
Salih, Mohammed S.

Publication type:

Article

Characteristics and clinical outcome of pT1a-b node-negative breast cancer.

Published in:

Northern Clinics of Istanbul, 2021, v. 8, n. 2, p. 124, doi. 10.14744/nci.2020.06332

By:

Oyman, Abdilkerim;
Basak, Mustafa;
Odabas, Hatice;
Ozcelik, Melike

Publication type:

Article

Prognostic and Predictive Significance of HER2-low Expression in Metastatic Hormone Receptor Positive Breast Cancer Patients Receiving CDK4-6 Inhibitor Therapy.

Published in:

European Journal of Therapeutics, 2024, v. 30, n. 5, p. 662, doi. 10.58600/eurjther2151

By:

Arak, Hacı;
Kuş, Tulay

Publication type:

Article

Adherence to Aromatase Inhibitors among Postmenopausal Breast Cancer Patients in Middle Euphrates Region of Iraq.

Published in:

Kerbala Jorunal of Medicine, 2021, v. 14, n. 1, p. 2419

By:

Mjali, Ahmed;
Oudah, Alyaa Hadi;
Al-Shammari, Haider Hasan Jaleel;
Abbas, Nareen Tawfeeq

Publication type:

Article

Reduced camptothecin sensitivity of estrogen receptor‐positive human breast cancer cells following exposure to di(2‐ethylhexyl)phthalate (DEHP) is associated with DNA methylation changes.

Published in:

Environmental Toxicology, 2019, v. 34, n. 4, p. 401, doi. 10.1002/tox.22694

By:

Chou, Chon‐Kit;
Huang, Hurng‐Wern;
Yang, Chun‐Feng;
Dahms, Hans‐Uwe;
Liang, Shih‐Shin;
Wang, Tsu‐Nai;
Kuo, Po‐Lin;
Hsi, Edward;
Tsai, Eing‐Mei;
Chiu, Chien‐Chih

Publication type:

Article

Early-stage breast cancer: Update on management.

Published in:

Medicine Today, 2024, v. 25, n. 4, p. 45

By:

OFRI, ADAM;
CUI, REBECCA;
ELSTNER, KRISTEN;
KUMAR, SANJEEV;
WARRIER, SANJAY

Publication type:

Article

Real-World Observational Study of Incidence and Outcomes in an HR+/HER2– Early Breast Cancer Population with High-Risk of Recurrence in Finland.

Published in:

Oncology & Therapy, 2025, v. 13, n. 1, p. 185, doi. 10.1007/s40487-024-00324-0

By:

Singh, Ravinder;
Tuominen, Samuli;
Lassenius, Mariann I.;
Auvinen, Merja;
Torstensson, Astrid;
Wiklund, Tom

Publication type:

Article

Real-World Study of Adjuvant Biosimilar Trastuzumab-dkst for HER2-Positive Breast Cancer Treatment in a Brazilian Population.

Published in:

Oncology & Therapy, 2024, v. 12, n. 3, p. 437, doi. 10.1007/s40487-024-00284-5

By:

Gagliato, Debora;
Reinert, Tomás;
Rocha, Cláudio;
Tavares, Monique;
Pimentel, Sâmio;
Fuzita, William;
Araújo, Márcia;
Matias, Danielli;
Aleixo, Sabina;
França, Bruno;
Magaton, Érida;
Brito, Natália;
Cardoso, Ana Carolina;
Castilho, Vivienne

Publication type:

Article

Exploring a Novel Approach to Spare Classic Chemotherapy in HER2-Low, ER-Positive Breast Cancer Based on Trastuzumab Deruxtecan Combined with Endocrine Therapy.

Published in:

2024

By:

Scafuri, Luca;
Buonerba, Carlo;
Di Lauro, Vincenzo;
Tortora, Vincenzo;
Cascella, Marco;
Liguori, Luigi;
Sciarra, Antonella;
Sabbatino, Francesco;
Diana, Anna;
Marra, Antonio;
Tarantino, Paolo;
Trapani, Dario;
Giuliano, Mario;
Arpino, Grazia;
Curigliano, Giuseppe;
Di Lorenzo, Giuseppe

Publication type:

Editorial

Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2− Metastatic Breast Cancer: A Podcast.

Published in:

Oncology & Therapy, 2023, v. 11, n. 4, p. 411, doi. 10.1007/s40487-023-00237-4

By:

Dong, Brian;
Lusen, Rita;
Chick, Ella;
Kline, Lisa

Publication type:

Article

Why is it important to define high risk of recurrence in early breast cancer?

Published in:

Oncolog-Hematolog, 2023, n. 65, p. 24

By:

Mazilu, Laura;
Popescu, Carmen

Publication type:

Article

Treatment options for HER2-positive metastatic breast cancer.

Published in:

Oncolog-Hematolog, 2020, n. 51, p. 28, doi. 10.26416/onhe.51.2.2020.3191

By:

Ciobotaru, Ciprian;
Călin Grigorescu, Alexandru

Publication type:

Article

Abstracts for National Conference of Medical Oncology - 19<sup>th</sup> edition.

Published in:: Oncolog-Hematolog, 2019, n. 48, p. 36
Publication type:: Article

Palliative Re-Irradiation of Bone Metastases - Case Report.

Published in:

Medicina Moderna, 2020, v. 27, n. 4, p. 313, doi. 10.31689/rmm.2020.27.4.313

By:

Teodor IANCU, Dragos Petru;
PAGUTE, Ovidiu Nicolae;
SAFTA, Cosmin;
MIRESTEAN, Camil Ciprian;
IANCU, Roxana Irina

Publication type:

Article

Luminal B 型乳腺癌不同亚型的临床病理特征及预后生存分析.

Published in:

Progress in Modern Biomedicine, 2022, v. 22, n. 12, p. 2366, doi. 10.13241/j.cnki.pmb.2022.12.034

By:

孙运坡;
金秉巍;
应学翔;
金艳凤;
沈容荣

Publication type:

Article

术前CA125、OPN、CXCL8、NLR 联合检测对乳腺癌改良根治术患者术后复发转移风险的评估价值.

Published in:

Progress in Modern Biomedicine, 2022, v. 22, n. 9, p. 1718, doi. 10.13241/j.cnki.pmb.2022.09.024

By:

刘贺;
张磊;
曹恒;
杜习成;
蒋宏传

Publication type:

Article

乳腺癌组织 FOXP3、HMGA2、RASAL2 的表达及与临床病理特征和预后的关系.

Published in:

Progress in Modern Biomedicine, 2021, v. 21, n. 20, p. 3959, doi. 10.13241/j.cnki.pmb.2021.20.032

By:

李会芳;
侯永强;
王明军;
陈涛;
刘金彪

Publication type:

Article

乳腺癌组织表皮生长因子受体、细胞角蛋白5/6、上皮钙黏蛋白表达与预后的关系研究.

Published in:

Progress in Modern Biomedicine, 2021, v. 21, n. 16, p. 3079, doi. 10.13241/j.cnki.pmb.2021.16.016

By:

喻兰雅;
寇晓梅;
柯永莉;
李燕;
李黎

Publication type:

Article

乳腺癌组织表皮生长因子受体、细胞角蛋白 5/6、上皮钙黏蛋白表达与预后的关系研究.

Published in:

Progress in Modern Biomedicine, 2021, n. 13, p. 3079, doi. 10.13241/j.cnki.pmb.2021.16.016

By:

喻兰雅;
寇晓梅;
柯永莉;
李燕;
李黎

Publication type:

Article

3.0 T 磁共振扩散加权成像在乳腺良恶性病变鉴别中的价值及较优b 值下ADC 值与预后因子相关性研究.

Published in:

Progress in Modern Biomedicine, 2020, v. 12, n. 24, p. 4679, doi. 10.13241/j.cnki.pmb.2020.24.017

By:

付金凤;
郭晓涵;
沈文荣;
顾晓荣;
尹娜;
刘念龙

Publication type:

Article

乳腺癌患者新辅助化疗后ER、PR、HER2、Ki67 表达变化及临床意义.

Published in:

Progress in Modern Biomedicine, 2020, v. 20, n. 11, p. 1997, doi. 10.13241/j.cnki.pmb.2020.10.044

By:

崔志超;
周立芝;
马杰;
王雅琪;
谷峥;
常猛;
胡继卫;
张景华;
杨超

Publication type:

Article

乳腺癌患者改良根治术后生活质量调查及复发转移的影响因素分析.

Published in:

Progress in Modern Biomedicine, 2020, v. 20, n. 5, p. 984, doi. 10.13241/j.cnki.pmb.2020.05.041

By:

黄正春;
杨枋;
孙智强;
霍明生;
朱斌;
俞欣

Publication type:

Article

乳腺癌中CELF6的表达水平及其与预后的关系.

Published in:

Progress in Modern Biomedicine, 2019, v. 19, n. 19, p. 3601, doi. 10.13241/j.cnki.pmb.2019.19.001

By:

张倩文;
柳刚;
夏丽;
李佳;
许乃寒

Publication type:

Article

Oxygen-ozone autohemotherapy in breast cancer patients suffering from fatigue and musculoskeletal pain upon aromatase inhibitors treatment: a case-series study.

Published in:

European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 23, p. 11643

By:

TIRELLI, U.;
VALDENASSI, L.;
FRANZINI, M.;
PANDOLFI, S.;
FISICHELLA, R.;
CHIRUMBOLO, S.

Publication type:

Article

Distinct discrepancy in breast cancer organoids recapitulation among molecular subtypes revealed by single‐cell transcriptomes analysis.

Published in:

Clinical & Translational Medicine, 2024, v. 14, n. 9, p. 1, doi. 10.1002/ctm2.70023

By:

Jia, Ziqi;
Xu, Hengyi;
Zhang, Yaru;
Cao, Heng;
Deng, Chunyu;
Xu, Longchen;
Sun, Yuning;
Li, Jiayi;
Huang, Yansong;
Pu, Pengming;
Shang, Tongxuan;
Wang, Xiang;
Su, Jianzhong;
Liu, Jiaqi

Publication type:

Article

Efficacy and safety of pyrotinib combined with albumin‐bound paclitaxel as first‐line treatment for HER2‐positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single‐arm, phase 2 prospective clinical trial

Published in:

Clinical & Translational Medicine, 2024, v. 14, n. 5, p. 1, doi. 10.1002/ctm2.1687

By:

Man, Xiaochu;
Huang, Jie;
Sun, Shujuan;
Zhou, Dongdong;
Zhang, Baoxuan;
Fang, Shu;
Zheng, Fangchao;
Li, Chao;
Wang, Xinzhao;
Huang, Wei;
Wang, Linlin;
He, Qingqing;
Fu, Hui;
Zhang, Yan;
Liu, Changrui;
Dong, Lin;
Zhao, Xianguang;
Xu, Liang;
Sun, Xiao;
Fan, Bingjie

Publication type:

Article

Molecular features of luminal breast cancer defined through spatial and single‐cell transcriptomics.

Published in:

Clinical & Translational Medicine, 2024, v. 14, n. 1, p. 1, doi. 10.1002/ctm2.1548

By:

Yoshitake, Ryohei;
Mori, Hitomi;
Ha, Desiree;
Wu, Xiwei;
Wang, Jinhui;
Wang, Xiaoqiang;
Saeki, Kohei;
Chang, Gregory;
Shim, Hyun Jeong;
Chan, Yin;
Chen, Shiuan

Publication type:

Article

Predictive value of DOT1L mutations for clinical outcomes in non‐small‐cell lung cancer patients receiving immune checkpoint inhibitor therapy.

Published in:

Clinical & Translational Medicine, 2023, v. 13, n. 10, p. 1, doi. 10.1002/ctm2.1430

By:

Guo, Tianxing;
Wang, Zhaofeng;
Wang, Song;
Zhang, Yaru;
Pang, Jiaohui;
Ying, Yajun;
Ou, Qiuxiang;
Shen, Dong;
Li, Gang

Publication type:

Article

17‐β‐estradiol reduces surface PD‐L1 expression in estrogen receptor‐positive breast cancer but not type 1 endometrial cancer cells.

Published in:

Clinical & Translational Medicine, 2023, v. 13, n. 7, p. 1, doi. 10.1002/ctm2.1330

By:

Li, Hongzhuo;
Gu, Wenyi;
Jeffery, Penny;
Chen, Chen

Publication type:

Article

KPNA1 regulates nuclear import of NCOR2 splice variant BQ323636.1 to confer tamoxifen resistance in breast cancer.

Published in:

Clinical & Translational Medicine, 2021, v. 11, n. 10, p. 1, doi. 10.1002/ctm2.554

By:

Tsoi, Ho;
Man, Ellen PS;
Leung, Man‐Hong;
Mok, Ka‐Chun;
Chau, Ka‐Man;
Wong, Lai‐San;
Chan, Wing‐Lok;
Chan, Sum‐Yin;
Luk, Mai‐Yee;
Cheng, Cheuk‐Nam;
Khoo, Ui‐Soon

Publication type:

Article

Aromatase inhibitor-induced arthralgia ameliorated by Mediterranean diet and active lifestyle guided by continuous glucose monitoring: a case report and review of the literature.

Published in:

Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1189287

By:

Wilson, Kalin L.;
Grewelle, Richard E.;
Gupta, Tanya;
Kim, Sun H.;
Katsumoto, Tamiko R.

Publication type:

Article

Aromatase inhibitors: the journey from the state of the art to clinical open questions.

Published in:

Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1249160

By:

Generali, Daniele;
Berardi, Rossana;
Caruso, Michele;
Cazzaniga, Marina;
Garrone, Ornella;
Minchella, Ida;
Paris, Ida;
Pinto, Carmine;
De Placido, Sabino

Publication type:

Article